Skip to Main text

Middle East, Africa

About Us

The Nitto Group strives to become a centennial company that is always trusted by customers, embraced by employees with pride, makes an active contribution to society, and continuously grows on a global scale.

The Nitto Group strives to become a centennial company that is always trusted by customers, embraced by employees with pride, makes an active contribution to society, and continuously grows on a global scale.

What's New RSS

The Nitto website is currently under system maintenance. Please try again later.
2019/Jan/08 Additional Approvals for Bisono®Tape, a Transdermal Patch containing a β1Blocker, for Atrial Fibrillation, for a 2 mg strength and for improved formulations of 4 mg and 8 mg strengths in Japan
2018/Dec/21 Report on the Nitto ATP Finals Charity Programs
2018/Nov/29 Nitto announces Phase I clinical trial of NBF-006 for the treatment of KRAS driven tumors in advanced cancer patients is allowed to proceed by the FDA

Back to Page Top